Of note, five of the sixteen young patients (31.2%) who lacked any traditional cancer risk factors (tobacco and/or alcohol use and also p16 positivity) were immunocompromised (three after bone marrow transplantation, one with Crohn’s disease, one during pregnancy) however their number was insufficient for a subgroup analysis. The gene discussed is CDKN2A; the disease is Crohn disease.